AGP Wire

AGP

China Orthopedic Power Tool Manufacturers are being positioned as a procurement option for Mexico’s hospitals, clinics, distributors, and surgical centers because of their manufacturing depth, customization options, and export support.

AGP

TRAFFIX’s August 2026 NAX Index shows U.S.-Canada and U.S.-Mexico freight lanes remained above neutral for a second straight month, signaling tight truck capacity, higher costs and more regulatory pressure for shippers.

AGP

Breathwork pioneer Dan Brulé is taking a new global push to India and Mexico City after speaking at Mindvalley U in Tallinn, Estonia, where he led sessions on practical breathing techniques for resilience, health and performance.

AGP

Valkit.ai has chosen Provalis Latam as its exclusive regional partner for Latin America, linking its AI-native digital validation platform with Provalis Latam’s GMP and compliance expertise across the region.

AGP

The market for non-invasive brain trauma monitoring devices is projected to rise from $10.73 billion in 2026 to $16.71 billion by 2030, according to The Business Research Company.

AGP

The Business Research Company says the global neurology monitoring market is set to grow from $7.34 billion in 2026 to $9.08 billion by 2030, fueled by more complex neurological surgeries, rising traumatic brain injuries and wider use of…

AGP

The market for neurology diagnostic and monitoring devices is projected to rise from $9.32 billion in 2025 to $10.19 billion in 2026, with growth tied to aging populations, rising neurological disease rates and better imaging tools.

AGP

The neurosurgical robotics market is projected to grow from $4.74 billion in 2026 to $8.04 billion by 2030, according to The Business Research Company.

AGP

The neuro-navigation systems market is projected to rise from $3.13 billion in 2025 to $4.96 billion by 2030, driven by more neurological disorders, more precise neurosurgery and wider use of imaging and AI. North America led in 2025, while…

AGP

The Business Research Company projects the next-generation oncology devices and solutions market will rise from $16.41 billion in 2025 to $19.46 billion in 2026, then nearly double again to $38.19 billion by 2030. Growth is being driven by higher…

AGP

The nephrostomy bags market is projected to rise from $1.16 billion in 2025 to $1.25 billion in 2026, then reach $1.65 billion by 2030, according to The Business Research Company.

AGP

Upgames used its first SiGMA South America appearance in São Paulo to pitch its mini game portfolio, meet regional operators and platform partners, and gauge demand across a fast-growing Latin American market.

AGP

Upgaming’s sportsbook was named a finalist for Best Interactive Sportsbook Experience 2026 at the SiGMA South America Awards 2026. The recognition comes as the company expands in Latin America, including support for Brazil’s newly regulated online…

AGP

The Business Research Company projects the next generation sequencing market will grow from $16.31 billion in 2026 to $28.59 billion by 2030, driven by precision medicine, oncology diagnostics and wider genomics research.

AGP

The global market for non-PVC IV bags is projected to grow from $2.52 billion in 2026 to $3.8 billion by 2030, driven by demand for safer, more sustainable medical consumables and tighter material-safety rules.

AGP

The market for non-invasive cholesterol readers is projected to rise from $1.3 billion in 2025 to $2.63 billion by 2030, driven by cardiovascular disease prevalence, healthcare spending and demand for painless testing.

AGP

Upgaming used SiGMA South America 2026 in São Paulo to deepen ties with operators and partners across Latin America as regulated online gaming grows.

AGP

The Business Research Company projects steady growth in the global neurovascular embolization devices market, driven by rising hemorrhage cases, broader use of neurointerventional procedures and stronger demand for minimally invasive stroke care….

AGP

The Business Research Company says the nerve conduit market will grow from $2.17 billion in 2026 to $2.99 billion by 2030, driven by more peripheral nerve injuries, neurological disorders and demand for regenerative repair options.

AGP

The Business Research Company says the global neurointerventional devices market is on track to grow from $2.76 billion in 2025 to $3.91 billion by 2030, driven by stroke, aneurysm and aging-population demand.